HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Bayer AG

https://www.bayer.com/

Latest From Bayer AG

AnGes To Withdraw, Refile HGF Gene Therapy In Japan

Bookmark
  • Analysis
By Lisa Takagi

If finally fully approved in its first indication, the HGF gene therapy could become a first-in-class therapy for PAD - but only after years of challenges in clinical trials.

Japan Gene Therapy

Merck Takes Over Orion-Partnered Prostate Cancer Drug MK-5684

Bookmark
  • News
By Alaric DeArment

Deal Snapshot: Merck said it would pay potentially more than $1.6bn for an exclusive global license for opevesostat for metastatic castrate-resistant prostate cancer.

Deals Business Strategies

Quick Listen: Scrip's Five Must-Know Things

Bookmark
  • News
By Ian Haydock

In this week's podcast edition of Five Must-Know Things: global CEO remuneration; another late-stage loss for Merch KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models.

Clinical Trials Commercial

Bayer's Bets In Parkinson's Start To Bear Fruit

Bookmark
  • Interviews
By Kevin Grogan

The German major is kicking off Phase II trials for a cell therapy and a gene therapy that could be gamechangers for the progressive neurodegenerative disorder that affects more than 10 million people worldwide.

Regenerative Medicine Clinical Trials
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
    • Radiopharmaceuticals, Contrast Agents
  • Digital Health
    • Artificial Intelligence
  • Other Names / Subsidiaries
    • Actus Therapeutics, Inc.
    • AskBio
    • Asklepios BioPharmaceutical, Inc.
    • Synpromics, Ltd.
    • RoverMed BioSciences
    • NanoCor Therapeutics
    • BrainVectis
    • Algeta ASA
    • Bayer CropScience AG
    • Bayer Consumer Care AG
    • Berlex Laboratories
    • BlueRock Therapeutics
    • Conceptus Inc.
    • Dihon Pharmaceutical Group Co., Ltd.
    • Intendis GmbH
    • Jenapharm
    • Medrad Inc.
    • Possis Medical
    • Schering AG
    • Monsanto Company
    • Zeptosens AG
    • KaNDy Therapeutics
    • Vividion Therapeutics, Inc.
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By